|
Market Closed -
NYSE
16:03:37 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 384.97 USD | -0.99% |
|
+4.83% | +50.30% |
| 08-13 | Humana agrees not to reference Teva's Israel ties at US drug trial | RE |
| 08-11 | Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce | CI |
| Market Cap | 46.23B 40.07B 37.56B 34.25B 64.44B 4,412B 65.48B 442B 173B 2,209B 174B 170B 7,367B | P/E 2026 * |
53.8x | P/E 2027 * | 23.7x |
|---|---|---|---|---|---|
| Enterprise Value | 53.73B 46.58B 43.66B 39.81B 74.91B 5,128B 76.11B 514B 201B 2,567B 202B 197B 8,564B | EV / Sales 2026 * |
0.33x | EV / Sales 2027 * | 0.31x |
| Free-Float |
60.3% | Yield 2026 * |
0.96% | Yield 2027 * | 0.99% |
Last Transcript: Humana Inc.
| 1 day | -0.99% | ||
| 1 week | +4.83% | ||
| Current month | +5.80% | ||
| 1 month | -5.18% | ||
| 3 months | +26.28% | ||
| 6 months | +109.11% | ||
| Current year | +50.30% |
| 1 week | 370.38 |  | 393.48 |
| 1 month | 353.69 | | 428.88 |
| Current year | 163.11 | | 428.88 |
| 1 year | 163.11 | | 428.88 |
| 3 years | 163.11 | | 530.54 |
| 5 years | 163.11 | | 571.3 |
| 10 years | 163.11 | | 571.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Rechtin
CEO | Chief Executive Officer | 55 | 2024-06-30 |
Celeste Brown
DFI | Director of Finance/CFO | 49 | 2025-01-10 |
Bobby Mukundan
CTO | Chief Tech/Sci/R&D Officer | - | 2026-04-09 |
| Director | Title | Age | Since |
|---|---|---|---|
Kurt Hilzinger
CHM | Chairman | 65 | 2013-12-31 |
Frank D'Amelio
BRD | Director/Board Member | 68 | 2003-08-31 |
Karen Katz
BRD | Director/Board Member | 69 | 2019-09-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/1/26 | Other | Director | 544 | 0.0005% | ||
| 8/1/26 | Free | Director | 544 | 0.0005% | ||
| 7/28/26 | Other | Director | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.99% | +4.83% | +36.52% | -22.06% | 46.23B | |
| -1.61% | -1.22% | +46.82% | -21.45% | 358B | |
| -0.23% | +1.74% | +35.25% | -16.00% | 86.36B | |
| +0.21% | +1.00% | -3.17% | -3.98% | 73.46B | |
| -1.54% | +2.87% | +143.96% | +0.43% | 32.62B | |
| -0.17% | +7.21% | +27.60% | -34.85% | 10.72B | |
| -0.44% | +0.60% | -8.81% | +105.18% | 2.79B | |
| -1.10% | -3.65% | +71.37% | +199.33% | 2.38B | |
| +1.85% | -14.30% | +12.27% | -33.10% | 1.99B | |
| Average | -0.23% | -0.24% | +40.20% | +19.28% | 68.3B | |
| Weighted average by Cap. | -0.04% | +0.28% | +43.00% | -16.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 163B 141B 132B 121B 227B 15,532B 231B 1,557B 608B 7,775B 611B 598B 25,936B | 169B 146B 137B 125B 235B 16,104B 239B 1,614B 630B 8,061B 633B 620B 26,891B |
| Net income | 886M 768M 720M 656M 1.24B 84.55B 1.25B 8.48B 3.31B 42.32B 3.33B 3.25B 141B | 2.02B 1.75B 1.64B 1.49B 2.81B 192B 2.86B 19.3B 7.53B 96.35B 7.57B 7.41B 321B |
| Net Debt | 7.51B 6.51B 6.1B 5.56B 10.46B 716B 10.63B 71.82B 28.04B 359B 28.18B 27.57B 1,196B | 6.41B 5.56B 5.21B 4.75B 8.94B 612B 9.08B 61.33B 23.94B 306B 24.07B 23.54B 1,022B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | US$384.97 | -0.99% | 754,149 |
| 26-08-12 | US$388.83 | +4.29% | 1,258,739 |
| 26-08-11 | US$372.82 | -3.34% | 733,248 |
| 26-08-10 | US$385.70 | +0.18% | 1,150,468 |
| 26-08-07 | US$385.00 | +4.84% | 1,405,174 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HUM Stock
Select your edition
All financial news and data tailored to specific country editions
